Michael H. Criqui, MD, MPH , is Distinguished Professor and Chief, Division of Preventive Medicine, in the Department of Family Medicine and Public Health at the University of California, San Diego (UCSD) School of Medicine. He also holds a joint appointment as Distinguished Professor, Division of Cardiology, in the Department of Medicine at UCSD, and he is Director of the Preventive Cardiology Academic Award Program at UCSD. Dr Criqui received his MD and did his residency training at the University of California, San Francisco and received his MPH in epidemiology from the University of California, Berkeley. He is Board Certified in General Preventive Medicine by the American College of Preventive Medicine.
Dr. Criqui is an active and productive investigator in cardiovascular epidemiology and preventive cardiology, and has made seminal contributions in the fields of subclinical atherosclerosis, peripheral arterial disease, and peripheral venous disease. He has published over 500 manuscripts and book chapters, and has been an invited lecturer at numerous national and international medical meetings. He is the recipient of several research grants and contracts, and is currently the Director of the NHLBI funded T32 training program at UCSD in cardiovascular epidemiology and prevention. He has mentored numerous students, residents and fellows.
Dr. Criqui is a Fellow of the following societies: the American College of Preventive Medicine, the American College of Epidemiology, the Society for Vascular Medicine, the Council on Peripheral Vascular Disease of the American Heart Association (AHA), and the Council on Epidemiology and Prevention of the AHA , for which he served as Chair. He is past Chair of the Interdisciplinary Committee on Prevention for the AHA . He currently chairs the International Peripheral Arterial Disease Working Group, for the Global Burden of Diseases, Injuries, and Risk Factors Study. He has served on committees for the National Institutes of Health, the Food and Drug Administration, the Centers for Disease Control, the World Health Organization, and the Institute of Medicine.
He is the recipient of several honors including election to the American Epidemiological Society (1984), the Joseph E. Stokes III Preventive Cardiology Award from the American Society for Preventive Cardiology (2001), the Frederick H. Epstein Memorial Lecture Award from the European Society of Cardiology Working Group on Epidemiology and Prevention (2002), the Special Recognition Award from AHA Council on Epidemiology and Prevention (2004), the Distinguished Achievement Award from the AHA Council on Epidemiology and Prevention (2008), the President’s Award for Vision from the Vascular Disease Foundation (2010), the Marcus Award for Distinguished Contribution as a Gifted Teacher from the International Academy of Cardiology (IAC) (2011), the IAC Distinguished Fellowship award (2013, and the Ancel Keys Memorial Lecturer Award from the AHA. In 2010, he was named a Distinguished Scientist of the American Heart Association, the organization’s highest scientific award.
Dr. Anderson's research focuses on nutrition and chronic disease prevention. She is an active researcher in cardiovascular epidemiology, and is the principal investigator of an NHLBI-funded study of the effects of dietary sodium and potassium intake on cardiovascular disease. She is the also the principal investigator of a behavioral intervention study for adherence to current dietary sodium recommendations. She is a co-investigator on the NIDDK-funded national multicenter Chronic Renal Insufficiency Cohort Study, which aims to identify risk factors and mechanisms of progressive renal disease and cardiovascular events in individuals with chronic kidney disease.
Dr. Anderson is a Fellow of the American Heart Association, and is a member of the leadership committee of the American Heart Association's councils on Epidemiology and Nutrition Physical Activity and Metabolism. She is also a member of the Pan American Health Organization’s (PAHO) Expert Group on Cardiovascular Disease Prevention through Dietary Salt Reduction, and the World Health Organization’s International Agency for Research on Cancer (IARC) committee on nutrition and physical (in)activity as determinants of cancer risk in Africa. She has also served on committees of the institute of Medicine (IOM), and in 2011 was appointed to the IOM’s standing Food and Nutrition Board. Additional honors and awards include the prestigious Gil Omenn Award for Academic Excellence (2001), Dannon Nutrition Leadership Institute Scholar (2003), and a Volunteer Service Award from the National Kidney Foundation of Maryland (2010).
Vibha Bhatnagar, MD, MPH, is a family medicine physician and clinical epidemiologist with diverse clinical and research experience. Her research focuses on analyzing cohort studies and developing analytic databases from electronic medical records. This work includes analysis of genetic determinants of complex diseases such as hypertension and chronic kidney disease.
Amelia Eastman, DO, Assistant Clinical Professor, attended medical school at Western University of Health Sciences and completed residencies in physical medicine and rehabilitation at Baylor College of Medicine, and in preventive medicine at UC San Diego. She is board-certified in the fields of physical medicine and rehabilitation, as well as in preventive medicine. Additionally, Dr. Eastman is a member of the Exercise and Physical Activity Resource Center (EPARC) at the California Institute for telecommunications and Information Technology, and a reviewer for the American Journal of Preventive Medicine. Dr. Eastman's research interest include sports concussion, back pain in workers, and validating objective physical activity and performance measures. She is involved in numerous research trials in the areas of pain, functional decline, fall prevention, and exercise, and has two patents pending for medical inventions to improve functional performance. Before attending medical school, Dr. Eastman worked as a professional mountain and river guide in South America and New Zealand. In addition, she has lived and worked in health care in Africa and Australia.
Dr. Gunn joined the UCSD Department of Family Medicine and Public Health in 1993 and is currently an Adjunct Professor, Division of Preventive Medicine. He has published numerous articles about sexually transmitted infections (STDs, HIV, and viral hepatitis). His current interests involve integration of prevention services into routine medical care.
is a nephrologist and clinical investigator at the University of California, San Diego. Dr. Ix is currently Professor of Medicine and Chief of the Division of Nephrology-Hypertension in the Department of Medicine and holds a joint appointment with the Veterans Affairs San Diego Healthcare System in La Jolla, California.
Dr. Joachim Ix's primary research interest is to delineate how metabolic complications of chronic kidney disease contribute to cardiovascular disease. His research focuses on aberrant regulation of calcium, phosphate, and associated regulatory hormones in the setting of chronic kidney disease. He has evaluated their relationships with vascular calcium deposition, arterial stiffness, cardiac structural changes, and cardiovascular disease events. He is also interested in the relationship of aberrant mineral metabolism with bone disease and with the rate of progression of chronic kidney disease and has used large scale datasets to understand these relationships in different observational settings. Dr. Ix is particularly interested in identifying novel therapies to intervene on altered mineral metabolism in chronic kidney disease patients. He has tested novel therapies using small scale, cross-over studies that involve intensive monitoring in general clinical research study (GCRC) settings. More recently, he is leading larger scale multi-center randomized placebo controlled studies testing novel therapies in chronic kidney disease patients.
Deborah Kado MD, MS is Associate Professor in the University of California, San Diego School of Medicine. She is an internist and geriatrician with a primary research focus on osteoporosis and the related disorder hyperkyphosis. She is a successfully funded National Institute's of Health researcher and is internationally recognized in her field of expertise. Dr. Kado graduated from Cornell University Medical College, completed her residency in internal medicine, served as chief resident, and then did post-residency fellowships in clinical research at UCSF and in geriatrics at UCLA. She subsequently completed a Master of Sciences Degree in Epidemiology at the UCLA School of Public Health.
Prior to joining UCSD School of Medicine, she served as faculty in geriatrics and orthopaedic surgery from July 2000 through July 2012. At the UCSD School of Medicine, she serves as the Deputy Director of Clinical Research and Education for the Stein Institute for Research on Aging and also is the Osteoporosis Clinic Director for the UCSD Health System. Dr. Kado has a joint appointment in the Division of Preventive Medicine, Department of Family Medicine and Public Health and the Division of Endocrinology, Department of Medicine, and is an associate member of the UC San Diego Moores Cancer Center. She is the principal or co-investigator on NIH RO1 funded studies on hyperkyphosis and other age-related conditions, she teaches in the medical school, and she sees patients through the Division of Endocrinology in La Jolla, California.
Based on her extensive experience in operationalizing community-based research projects, Dr. Pakiz has collaborated with investigators at the Cancer Prevention and Control Program at the UC San Diego Moores Cancer Center and has assisted them with the overall conduct of a number of clinical trials that focus on obesity, behavioral weight loss interventions, and behavioral and metabolic factors associated with disease risk. She is the project director of the UCSD TREC (Transdisciplinary Research on Energetics and Cancer) Center, one of four TREC centers across the US funded by the National Institutes of Health (NIH). The UCSD TREC Center includes four studies that focus on mechanisms linking obesity with breast cancer risk investigate obesity and lifestyle factors related to insulin resistance and inflammation, using mouse models and clinical trials. One of the three TREC clinical trials is the Diet Composition and Genetics: Effects on Weight, Inflammation and Biomarkers study. This project involves a 12-month behavioral weight loss program with 245 obese women assigned to three study arms with different dietary composition. The results will help to refine dietary guidance for optimal weight control and breast cancer prevention and will contribute to knowledge of mechanisms that link insulin resistance, inflammation and obesity to breast cancer risk and progression. Dr. Pakiz also was a Co-Investigator for the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) study, funded by the National Institutes of Health (NIH). This was a 4-year, multi-site randomized clinical trial of 693 overweight/obese breast cancer survivors, designed to demonstrate the feasibility of achieving sustained weight loss and to examine the impact of weight loss on quality of life and co-morbidities. Other recent studies she has directed include an industry-sponsored trial that tested whether providing portion-controlled prepackaged lunch and dinner entrées in the context of a reduced-energy diet prescription and behavioral counseling promotes greater weight loss in overweight and obese men and women (N=183), compared to control conditions where the prescribed diet is consumed via self-selected foods.
Kevin Patrick, MD, MS is Professor and Editor-in-Chief of the American Journal of Preventive Medicine. He leads an interdisciplinary group researching the use of mobile and web technologies to measure and improve physical activity and diet behaviors in the context of conditions such as obesity, depression, successful aging and diabetes prevention and management. He is a Senior Advisor to the Robert Wood Johnson (RWJ) Foundation's Active Living Research program and is a member of the National Advisory Boards for RWJ's Health e-Technology and Games for Health initiatives.
Dena Rifkin, MD, MS is a nephrologist and epidemiologist. She received her MD degrees from Yale University and her master's in epidemiology from Tufts University. Her research interests include investigations of aging and kidney disease and issues of medication use patterns and safety in kidney disease.
Dr. Rock’s research efforts are focused on the role of nutritional and dietary factors in the development and progression of cancer, particularly breast cancer, and healthy weight management in adults. Her research efforts address diet composition and weight management, and how diet, adiposity and physical activity affect biomarkers and risk and progression of cancer and other chronic diseases. Dr. Rock is presently responsible for randomized trials funded by the National Institutes of Health (NIH) that are testing whether healthy weight control and modifications in diet and physical activity can alter biological processes, hormonal factors, and biomarkers of disease progression. In addition to also serving as principal investigator for industry-sponsored randomized clinical trials of weight loss programs and strategies, she is a co-investigator on several NIH-funded studies that are focused on obesity, various weight loss interventions, and behavioral and metabolic factors associated with disease risk. Dr. Rock also leads the Diet and Physical Activity Shared Resource of the UC San Diego Moores Cancer Center, a laboratory and dietary assessment and counseling recharge service unit that is focused on identifying and measuring dietary biomarkers, improving dietary assessment methods, and facilitating behavioral interventions.
Dr. Rock has served on numerous NIH and USDA review panels and committees, and she currently serves on editorial boards for several peer-reviewed journals. To date, Dr Rock is the author of more than 260 scientific papers and book chapters.
Dorothy Sears, PhD is an Associate Professor with a primary appointment in the Department of Medicine, Division of Endocrinology & Metabolism and a secondary appointment in the Department of Family Medicine and Public Health, Division of Preventive Medicine. She has been conducting obesity and type 2 diabetes-related research since 1995. She is an internationally recognized expert in these fields, and has recently broadened her focus to include obesity-related cancer and disease prevention. Her publications have been cited in >1100 research articles (Web of Knowledge). Dr. Sears uses a variety of analytical approaches to identify and characterize genes, metabolites, and physiological pathways that are regulators and biomarkers of disease/disease risk and which can be used as novel targets for disease risk reduction, therapy, and/or diagnosis. She is/has been Principal Investigator of clinical trials testing novel dietary and sedentary behavioral interventions for reducing chronic disease risk, a multi-site project assessing baseline and intervention-induced changes in breast cancer recurrence and mortality biomarkers, and a multi-site project assessing the lipid profiles in three mouse models of obesity-related cancer. Dr. Sears is a member of the UCSD Transdisciplinary Research in Energetics and Cancer (TREC) Center, the FMPH Energy Balance, Obesity and Cancer Prevention Center of Excellence, the FMPH Women’s Health Center of Excellence, the Center for Circadian Biology, the Diabetes Research Center, and the Moores Cancer Center. Dr. Sears is a faculty member of the UCSD Bioinformatics & Systems Biology Graduate Program.
UCSD School of Medicine & Health Sciences service: Dr. Sears has served the School of Medicine as Chair of the Recruitment and Admissions Committee (RAC), and as a member of the Health Sciences Faculty Council, the Committee on Educational Policy, and the Core Curriculum Committee. She currently serves on the Department of Medicine Committee on Academic Personnel, the RAC Executive Committee, and the Women in Health Sciences Committee (of which she is a co-founder).
Community service: Dr. Sears actively supports the local and national American Diabetes Association (ADA). She is currently President of the Greater San Diego ADA Community Leadership Board, and is a member of the Advocacy Committee and Speakers Bureau. She has served as a grant reviewer for many agencies including the ADA, NIH, the Doris A. Howell Foundation, and the Christian Doppler Research Association. Dr. Sears has been a member of the San Diego Chapter of the Association for Women in Science (AWIS-SD) since 2001 and had been very active in the leadership including serving as President (2010-2013). Dr. Sears has been honored several times for her community service including the Greater San Diego Area American Diabetes Association ACT Advocacy Award (2015), the Women Making History - Eleanor Roosevelt Hero Award (2013), and the AWIS-SD Outstanding Volunteer Award (2009).
Publications listed in Google Scholar profile: http://tinyurl.com/Sears-GoogleScholar
Yuyan Shi, PhD is a health policy analyst and health economist with research interests in policy and economic analysis of substance use and abuse. She obtained her Ph.D. degree in applied microeconomics and policy analysis with concentration on health economics from Pardee RAND Graduate School (RAND Corporation). She received master's degree in policy analysis from Tsinghua University, and Bachelor's degree from Peking University, China with double major in political science and economics. Before joining UCSD, she was a health economics consultant at the World Bank, and a health economist at the Healthways. Inc.
Dr. Shi’s research concentrates on tobacco, alcohol and marijuana use and abuse. She is interested in understanding the epidemiology and geographic patterns of these behaviors, evaluating the impacts of economics and health policies in vulnerable subgroups and in the general population as a whole, and conducting economic evaluations to assess cost-effectiveness/cost-utility/cost-benefit of behavioral interventions. Dr. Shi is particularly interested in novel tobacco products such as e-cigarettes and hookah, availability of marijuana products, economics of marijuana purchasing behaviors, and impacts of marijuana legalization policies on marijuana use in both adolescent and adult population. She is specialized in economics and statistical modeling, spatial analysis, and policy evaluation using large population data.
Dr. Shi teaches in the UCSD-SDSU Joint Doctoral Program (JDP) on Health Policy for Health Behavior, and in the UCSD Bachelor of Science in Public Health (BSPH) on Health Policy and Healthy Lifestyles. She is also a guest lecturer in BSPH Introduction to Public Health and an instructor for undergraduate independent research.
Google Scholar Profile: http://scholar.google.com/citations?user=7EQhcgUAAAAJ
Murray B Stein MD, MPH, FRCPC is Professor of Psychiatry and Family Medicine and Public Health at the University of California San Diego (UCSD), where he directs the Anxiety & Traumatic Stress Disorders Program. Dr. Stein graduated from the University of Manitoba and completed his residency and post-residency fellowship at the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland, USA. He subsequently completed a Master of Public Health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland.
Dr. Stein’s research interests include the epidemiology, neurobiology, and treatment of anxiety disorders especially social phobia, panic disorder, and posttraumatic stress disorder. He has written or co-written over 400 peer-reviewed scientific articles on these topics, including in journals such as The Lancet, Journal of the American Medical Association, American Journal of Psychiatry, and Archives of General Psychiatry. He is co-editor, with Martin Antony PhD, of the Oxford Handbook of Anxiety and Related Disorders (2009). His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment-resistant anxiety disorders, and functional neuroimaging research in anxiety and trauma-related disorders. He is Principal Investigator and Director of the Department of Defense-funded (2008-2013) INjury and TRaumatic STress (INTRuST) Consortium, which studies treatments for Posttraumatic Stress Disorder and Traumatic Brain Injury. He is also Co-Principal Investigator (with Robert Ursano MD) of Army STARRS, an NIMH-funded project (2009-2014) investigating risk factors for suicide and other deployment-related disorders.
Dr. Stein is a member of the Board of Directors of the Anxiety Disorders Association of America (ADAA), a Fellow of the American College of Neuropsychopharmacology (ACNP), Deputy Editor for Anxiety for the journal Depression & Anxiety, and Co-Editor-in-Chief for UpToDate in Psychiatry. He is a member of the editorial board of Psychological Medicine and Biological Psychiatry. Dr. Stein chaired the American Psychiatric Association Workgroup to Revise the Panic Disorder Treatment Guidelines (2006-2008), and is past Scientific Chair of the NIMH Interventions in Mood and Anxiety (ITMA) Review Group (2006-2009). Dr. Stein is a member of the DSM-5 Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic, and Dissociative Disorders Work Group (2009-present). He is also a member of the Psychopharmacologic Drugs Advisory Committee (PDAC) of the Food and Drug Administration (2011-2014).
C. Michael Wright, MD, FACC, DABCL is a voluntary professor in the Division of Preventive Medicine. He founded and headed the LifeScore Clinic from 1999-2007. The database of CT images and clinical data from the LifeScore Clinic has generated over 20 UCSD research papers on subclinical atherosclerosis in multiple vascular beds. Dr. Wright was the first physician in San Diego to offer coronary artery calcium screenings. The coronary artery calcium score has subsequently been proven to be the most accurate predictor of risk for heart attack. Recent papers have looked at the relationship of calcification in various arteries and mortality. Dr. Wright is board certified in Internal Medicine, Cardiovascular Disease and Clinical Lipidology. He is on staff at Scripps Memorial Hospital in La Jolla.
Section 'Sub' Navigation:
Page 'Breadcrumb' Navigation: